Catalyst Pharmaceuticals (CPRX) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Catalyst Pharmaceuticals (CPRX) over the last 15 years, with Q3 2025 value amounting to -$10.9 million.
- Catalyst Pharmaceuticals' Other Gross PP&E Adjustments fell 203.66% to -$10.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.9 million, marking a year-over-year decrease of 203.66%. This contributed to the annual value of -$12.2 million for FY2024, which is 9514.97% down from last year.
- As of Q3 2025, Catalyst Pharmaceuticals' Other Gross PP&E Adjustments stood at -$10.9 million, which was down 203.66% from -$19.7 million recorded in Q2 2025.
- Over the past 5 years, Catalyst Pharmaceuticals' Other Gross PP&E Adjustments peaked at -$1.4 million during Q1 2024, and registered a low of -$29.1 million during Q1 2025.
- Over the past 5 years, Catalyst Pharmaceuticals' median Other Gross PP&E Adjustments value was -$2.2 million (recorded in 2021), while the average stood at -$6.9 million.
- As far as peak fluctuations go, Catalyst Pharmaceuticals' Other Gross PP&E Adjustments plummeted by 1760362.46% in 2021, and later soared by 1658.23% in 2022.
- Catalyst Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$2.0 million in 2021, then rose by 12.13% to -$1.8 million in 2022, then crashed by 248.99% to -$6.2 million in 2023, then plummeted by 95.15% to -$12.2 million in 2024, then rose by 10.82% to -$10.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$10.9 million for Q3 2025, versus -$19.7 million for Q2 2025 and -$29.1 million for Q1 2025.